Arena Pharmaceuticals, Inc. Fair Value Assumptions, Weighted Average Volatility Rate (Deprecated 2018-01-31)
Arena Pharmaceuticals, Inc. reported Fair Value Assumptions, Weighted Average Volatility Rate (Deprecated 2018-01-31) of 75.00% for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-14.
Discontinued › Income Statement › Earnings Per Share
us-gaap:FairValueAssumptionsWeightedAverageVolatilityRate · last filed 2018-03-14
- Arena Pharmaceuticals, Inc. fair value assumptions, weighted average volatility rate (deprecated 2018-01-31) for fiscal 2017 was 75.00%, a 0.00% change from fiscal 2016.
- Arena Pharmaceuticals, Inc. fair value assumptions, weighted average volatility rate (deprecated 2018-01-31) for fiscal 2016 was 75.00%, a 0.00% change from fiscal 2015.
- Arena Pharmaceuticals, Inc. fair value assumptions, weighted average volatility rate (deprecated 2018-01-31) for fiscal 2015 was 75.00%, a 0.00% change from fiscal 2014.
- Arena Pharmaceuticals, Inc. fair value assumptions, weighted average volatility rate (deprecated 2018-01-31) for fiscal 2014 was 75.00%, a 0.00% change from fiscal 2013.
| Period end | Fair Value Assumptions, Weighted Average Volatility Rate (Deprecated 2018-01-31) 12 month |
|---|---|
| 2017-12-31 | 75.00% 10-K · filed 2018-03-14 |
| 2016-12-31 | 75.00% 10-K · filed 2017-03-15 |
| 2015-12-31 | 75.00% 10-K · filed 2016-02-29 |
| 2014-12-31 | 75.00% 10-K · filed 2015-03-02 |
| 2013-12-31 | 75.00% 10-K · filed 2014-03-03 |